Toho Acetylene Co.,Ltd. (4093.T) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	34.6B	34.6B	34.8B	35.4B	34.1B
Cost of Revenue	5.7B	23.3B	23.8B	24.2B	24.0B
Gross Profit	2.8B	11.2B	11.0B	11.2B	10.1B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	2.4B	9.3B	9.1B	9.1B	8.6B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	2.4B	9.3B	9.1B	9.1B	8.6B
Cost and Expenses	32.7B	32.7B	32.9B	33.3B	32.6B
Operating Income (EBIT)	1.9B	1.9B	1.9B	2.1B	1.5B
Non-Operating
Interest Income	593.0K	11.8M	3.5M	777.0K	808.0K
Interest Expense	13.7M	56.4M	42.8M	31.6M	31.3M
Net Interest Income	(13.1M)	(44.7M)	(39.2M)	(30.8M)	(30.5M)
Other Non-Op Income/Expense	67.3M	209.0M	255.8M	324.6M	162.1M
Non-Operating Income (excl Interest)	99.5M	303.1M	351.6M	431.6M	261.8M
EBT (Pre-Tax Income)	498.4M	2.1B	2.1B	2.4B	1.7B
Income Tax Expense	204.1M	674.0M	730.1M	823.6M	572.8M
Bottom Line
Net Income	1.3B	1.3B	1.3B	1.4B	988.0M
Earnings from Cont. Ops	—	—	—	—	—
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	1.3B	1.3B	1.3B	1.4B	988.0M
Per Share
Basic EPS	¥36	¥37	¥37	¥41	¥142
Diluted EPS	¥36	¥37	—	—	—
Revenue Per Share	¥995	¥994	¥1,001	¥1,019	¥4,909
Shares
Basic Shares Outstanding	34.8M	34.8M	34.8M	34.8M	6.9M
Diluted Shares Outstanding	—	—	—	—	—
Profitability Metrics
EBITDA	—	2.7B	2.6B	2.8B	2.2B
D&A	—	750.6M	696.0M	635.5M	630.7M
EBIT	1.9B	1.9B	1.9B	2.1B	1.5B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026